Invitrogen: Sep 7, 2006

Sep 07, 2006

Premium

Invitrogen has introduced Lipofectamine LTX, a transfection reagent for DNA delivery.

According to the company, the reagent demonstrates high levels of transfection efficiency and protein expression with more than 90 percent viability for a wide range of cells, including primary neuronal cells and other disease-relevant cell types.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Biden Cancer Initiative Suspends Work

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Not What Was Expected, Eh?

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.